Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: A multicentre, open-label, 52-week phase III trial
Journal of Neurology, Neurosurgery & Psychiatry | Aug 15, 2017
Anxiety contributes to poorer asthma outcomes in inner-city black adolescents
The Journal of Allergy and Clinical Immunology: In Practice | Aug 14, 2017
The clinical and mutational spectrum of Turkish patients with cystinosis
Clinical Journal of the American Society of Nephrology | Aug 14, 2017